Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about DNAJB6: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
| Gene Symbol | DNAJB6 |
| Chromosome | 7p12.3 |
| Protein Type | Chaperone |
| Target Class | Protein |
| Function | is an important component in the neurobiology of neurodegenerative diseases. |
| Mechanism of Action | Prioritized from 1 SciDEX hypotheses, including: HSP70 Co-chaperone DNAJB6 Universal Cross-Seeding Inhibitor |
| Primary Expression | Broad, high in muscle and brain |
| Druggability | Low (0.50) |
| Clinical Stage | Phase I |
| Molecular Weight | ~38 kDa |
| Amino Acids | 326 aa |
| Pathways | proteostasis |
| UniProt ID | O75146 |
| GeneCards | DNAJB6 |
| Human Protein Atlas | DNAJB6 |
| Associated Diseases | ALS, Alzheimer, Alzheimer's disease, Amyotrophic Lateral Sclerosis, Dementia |
| Known Drugs/Compounds | amyloid-beta 42 |
| Interactions | FUS, GAIN, HSP70, MYOT, NBR1, P62 |
| SciDEX Target | View Target Profile |
| SciDEX Hypotheses | HSP70 Co-chaperone DNAJB6 Universal Cross-Seeding |
| KG Connections | 471 knowledge graph edges |
| Databases | GeneCardsNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
DNAJB6["DNAJB6"]
Myofibrillar_Myopathy{"Myofibrillar Myopathy"}
DNAJB6 -->|"causes"| Myofibrillar_Myopathy
FLNC["FLNC"]
DNAJB6 -->|"degrades"| FLNC
MYOT["MYOT"]
DNAJB6 -->|"degrades"| MYOT
NBR1["NBR1"]
DNAJB6 -->|"degrades"| NBR1
P62["P62"]
DNAJB6 -->|"degrades"| P62
SQSTM1["SQSTM1"]
DNAJB6 -->|"degrades"| SQSTM1
HSP70("HSP70")
DNAJB6 -->|"interacts_with"| HSP70
alpha_synuclein("alpha-synuclein")
DNAJB6 -->|"inhibits"| alpha_synuclein
amyloid_beta("amyloid-beta")
DNAJB6 -->|"inhibits"| amyloid_beta
LGMDD1{"LGMDD1"}
DNAJB6 -->|"associated_with"| LGMDD1
Parkinson_s_disease{"Parkinson's disease"}
DNAJB6 -->|"protects_against"| Parkinson_s_disease
Alzheimer_s_disease{"Alzheimer's disease"}
DNAJB6 -->|"protects_against"| Alzheimer_s_disease
proteostasis(["proteostasis"])
DNAJB6 -->|"involved_in"| proteostasis
hnRNPA2B1("hnRNPA2B1")
DNAJB6 -->|"interacts_with"| hnRNPA2B1
FUS("FUS")
DNAJB6 -->|"modulates"| FUS| Target | Relation | Type | Str |
|---|---|---|---|
| Myofibrillar Myopathy | causes | disease | 0.95 |
| Amyloid Protein Aggregation | suppresses | process | 0.95 |
| Hsp70 | interacts_with | protein | 0.95 |
| LGMDD1 | causes | disease | 0.95 |
| Hsp70 | binds | protein | 0.95 |
| FUS condensates | inhibits | mechanism | 0.95 |
| phase separation | regulates | process | 0.93 |
| FUS fibrilization | inhibits | process | 0.92 |
| Amyloid Proteins | inhibits | protein | 0.90 |
| Hsp70 | activates | protein | 0.90 |
| Myofibrillar Degeneration | causes | phenotype | 0.90 |
| Neurodegeneration | protects_against | process | 0.90 |
| Alpha-Synuclein | suppresses | protein | 0.90 |
| Protein Aggregation | inhibits | process | 0.90 |
| Polyglutamine-Expanded Proteins | inhibits | protein | 0.85 |
| LGMDD1 | therapeutic_target | disease | 0.85 |
| Parkinson'S Disease | protects_against | disease | 0.85 |
| Alzheimer'S Disease | protects_against | disease | 0.85 |
| Proteostasis | regulates | process | 0.85 |
| TAU | regulates | protein | 0.80 |
| Huntington'S Disease | protects_against | disease | 0.80 |
| amyloid-beta 42 | inhibits | compound | 0.80 |
| oxidative stress response | participates_in | pathway | 0.80 |
| Synucleinopathies | protects_against | disease | 0.80 |
| Tauopathies | protects_against | disease | 0.80 |
| Huntington's disease | prevents | disease | 0.80 |
| Alzheimer's disease | blocks | disease | 0.80 |
| neurodegeneration | inhibits | disease | 0.70 |
| Alzheimer's disease | inhibits | disease | 0.70 |
| Huntington's disease | inhibits | disease | 0.70 |
| Alzheimer's disease | implicated_in | disease | 0.70 |
| neurons | activates | cell_type | 0.70 |
| neurons | protects_against | cell_type | 0.70 |
| ubiquitin-proteasome | participates_in | pathway | 0.70 |
| Encephalitis | inhibits | disease | 0.65 |
| Spinal Muscular Atrophy | inhibits | disease | 0.65 |
| PHB2 | protects_against | gene | 0.65 |
| Parkinson | inhibits | disease | 0.65 |
| Als | expressed_in | disease | 0.65 |
| Alzheimer | inhibits | disease | 0.65 |
| Als | inhibits | disease | 0.65 |
| Huntington | inhibits | disease | 0.65 |
| Als | associated_with | disease | 0.65 |
| Amyotrophic Lateral Sclerosis | associated_with | disease | 0.65 |
| Als | activates | disease | 0.65 |
| Dementia | associated_with | disease | 0.65 |
| Neurodegeneration | activates | disease | 0.65 |
| Neurodegeneration | associated_with | disease | 0.65 |
| Huntington | protects_against | disease | 0.65 |
| Parkinson | protects_against | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| h-c9486869 | targets_gene | hypothesis | 0.90 |
| HNRNPA2B1 | genetically_interacts | gene | 0.80 |
| BRCA1 | degrades | entity | 0.60 |
| DES | degrades | entity | 0.60 |
| HSP70 | interacts_with | gene | 0.60 |
| CHMP4B | associated_with | gene | 0.60 |
| FUS | activates | gene | 0.60 |
| HDAC4 | inhibits | gene | 0.60 |
| UBE2N | interacts_with | gene | 0.60 |
| BRCA1 | associated_with | gene | 0.60 |
| DES | associated_with | gene | 0.60 |
| P62 | associated_with | gene | 0.60 |
| NBR1 | associated_with | gene | 0.60 |
| MYOT | associated_with | gene | 0.60 |
| FLNC | associated_with | gene | 0.60 |
| GAIN | interacts_with | gene | 0.60 |
| DNAJB1 | stabilizes | gene | 0.60 |
| HSP70 | stabilizes | gene | 0.60 |
| DNAJA1 | stabilizes | gene | 0.60 |
| DNAJB2 | stabilizes | gene | 0.60 |
| GAIN | activates | gene | 0.60 |
| HUNTINGTIN | interacts_with | gene | 0.60 |
| PPP2CB | interacts_with | gene | 0.60 |
| DCTN1 | regulates | gene | 0.60 |
| DYNACTIN | regulates | gene | 0.60 |
| DYNEIN | regulates | gene | 0.60 |
| POLE | regulates | gene | 0.60 |
| HSP70 | inhibits | gene | 0.60 |
| TDP-43 | associated_with | gene | 0.60 |
| JNK | inhibits | gene | 0.60 |
| CDK4 | inhibits | gene | 0.60 |
| GAIN | expressed_in | gene | 0.60 |
| DNAJB1 | suppresses | gene | 0.60 |
| DNAJB1 | expressed_in | gene | 0.60 |
| DNAJB1 | degrades | gene | 0.60 |
| DNAJA1 | inhibits | gene | 0.60 |
| GENES | associated_with | gene | 0.60 |
| AND | associated_with | gene | 0.60 |
| AND | regulates | gene | 0.60 |
| GENES | inhibits | gene | 0.60 |
| AND | inhibits | gene | 0.60 |
| GENES | causes | gene | 0.60 |
| NEURODEGENERATION | activates | gene | 0.60 |
| DEMENTIA | associated_with | gene | 0.60 |
| NEUROTOXICITY | inhibits | gene | 0.60 |
| AND | interacts_with | gene | 0.60 |
| NEURODEGENERATION | associated_with | gene | 0.60 |
| AND | activates | gene | 0.60 |
| NEURODEGENERATION | expressed_in | gene | 0.60 |
| AUTOPHAGY | associated_with | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| HSP70 Co-chaperone DNAJB6 Universal Cross-Seeding Inhibitor | 0.420 | neurodegeneration | Protein aggregation cross-seeding across |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-12 | 0 hypotheses
neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.488
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| DNAJB6: A guardian against neurodegeneration. [PMID:40536953] | Hentze J, Gelman A, Brudek T, Hansen C | Neural regeneration research | 2026 | 0 |
| Multiplex neurodegeneration proteotoxicity platform reveals DNAJB6 promotes non- [PMID:41271702] | Resnick SJ, Qamar S, Krishna P, Korobeyn | Nature communications | 2025 | 0 |
| Extracellular chaperone networks and the export of J-domain proteins. [PMID:36581212] | Braun JEA | The Journal of biological chem | 2023 | 0 |
| DNAJB6 mutants display toxic gain of function through unregulated interaction wi [PMID:37923706] | Abayev-Avraham M, Salzberg Y, Gliksberg | Nature communications | 2023 | 0 |
| [WALANT - Wide Awake Local Anaesthesia No Tourniquet: Complications in elective [PMID:35168268] | Wieschollek S, Forster S, Megerle K | Handchirurgie, Mikrochirurgie, | 2022 | 0 |
| The chaperone DNAJB6 surveils FG-nucleoporins and is required for interphase nuc [PMID:36302971] | Kuiper EFE, Gallardo P, Bergsma T, Mari | Nature cell biology | 2022 | 0 |
| A 20-year Clinical and Genetic Neuromuscular Cohort Analysis in Lebanon: An Inte [PMID:34602496] | Megarbane A, Bizzari S, Deepthi A, Sabba | Journal of neuromuscular disea | 2022 | 0 |
| DNAJB6 suppresses alpha-synuclein induced pathology in an animal model of Parkin [PMID:34390836] | ["Arkan S", "Ljungberg M", "Kirik D", "H | Neurobiology of disease | 2021 | 0 |
| Engineering complex communities by directed evolution. [PMID:33986540] | Chang CY, Vila JCC, Bender M, Li R, Mank | Nature ecology & evolution | 2021 | 0 |
| Successful Nonoperative Treatment of Osteochondritis Dissecans of the Humeral Ca [PMID:34825100] | Tajika T, Kuboi T, Endo F, Hatori Y, Sai | Progress in rehabilitation med | 2021 | 0 |
| Panorama of the distal myopathies. [PMID:33458580] | Savarese M, Sarparanta J, Vihola A, Jons | Acta myologica : myopathies an | 2020 | 0 |
| Functional characterization of 84 PALB2 variants of uncertain significance. [PMID:31636395] | Wiltshire T, Ducy M, Foo TK, Hu C, Lee K | Genetics in medicine : officia | 2020 | 0 |
| DNAJB6, a Key Factor in Neuronal Sensitivity to Amyloidogenesis. [PMID:32268123] | ["Thiruvalluvan A", "de Mattos E", "Brun | Molecular cell | 2020 | 0 |
| Fibrinogen Induces Microglia-Mediated Spine Elimination and Cognitive Impairment [PMID:30737131] | Merlini M, Rafalski VA, Rios Coronado PE | Neuron | 2019 | 0 |
| Genetic landscape and novel disease mechanisms from a large LGMD cohort of 4656 [PMID:30564623] | Nallamilli BRR, Chakravorty S, Kesari A, | Annals of clinical and transla | 2018 | 0 |
| Emerging roles and underlying molecular mechanisms of DNAJB6 in cancer. [PMID:27276715] | Meng E, Shevde LA, Samant RS | Oncotarget | 2016 | 0 |